title: [Desensitization to lenalidomide].
authors: I
authors: I
authors: Cañamares Orbis
authors: C
authors: C
authors: García Muñoz
authors: S
authors: S
authors: Cortijo Cascajares
authors: M E
authors: ME
authors: Méndez Esteban
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide